An Open-Label, Randomized Pilot Study Comparing the Safety of a Single Dose of TNX-1300 to Usual Care (UC) Alone for the Treatment of Signs and Symptoms of Acute Cocaine Intoxication in Male Emergency Department (ED) Subjects

NCT04996056 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Not able to recruit qualified participants

Conditions

Cocaine Intoxication

Interventions

DRUG: TNX-1300
OTHER: Usual Care

Sponsor

Tonix Pharmaceuticals, Inc.